Germline genetic testing (GT) is recommended for men with prostate cancer (PC), but testing through traditional models is limited. The ProGen study examined a novel model aimed at providing access to ...

Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder. Genetic testing for the NF2 mutation is ...

Genetic testing can reveal whether or not you have a gene mutation that increases cancer risk. Knowing you’re at higher risk means you can take action to prevent cancer or find it early, when it is ...

Genetic testing for schwannomatosis is available and may be appropriate for some people. The current test identifies a mutation in the SMARCB1 gene, which predisposes an individual to developing the ...

Imagine you agreed to be part of a new and exciting long-term research study to better understand human health and behavior. For the past few years, you’ve been visiting a collection site where you ...

With around 280 million people worldwide living with a genetic disease, it’s crucial that expectant mothers and families seek genetic counseling as early as possible. “It’s not just about getting ...

Enrollment Success, Factors, and Prediction Models in Cancer Trials (2008-2019) Men with potentially lethal PC (metastatic, localized with a Gleason score of ≥8, persistent prostate-specific antigen ...